Cancer 
        Digest        

Metastatic melanoma cells – Image Credit National Cancer Institute CANCER DIGEST – Jan. 24, 2026 – When a personalized mRNA cancer vaccine is added to an immunotherapy for the treatment of advanced melanoma, more patients survived without recurrence than those treated with pembrolizumab (Keytruda®) alone, the five-year updated results of a clinical trial show. The KEYNOTE-942 ongoing clinical trial ( NCT03897881 ) compares the effectiveness of treatment of patients with stage

Patients with a rare skin cancer who received an immunotherapy drug after surgery had a 42 percent lower risk of the cancer spreading to other parts of the body.

Lung cancer patients who received COVID-19 vaccination survived nearly twice as long as similar patients who did not get the vaccine, a new observational study shows.

The IMA203 treatment uses T cells engineered to target the PRAME peptide, which is almost exclusively produced by solid tumors and not...

CANCER DIGEST – March 8, 2025 – When most people get a tattoo, their health concerns center almost entirely on cleanliness and risk of...

A drug, already approved for treating superficial melanomas, injected into basal cell tumors reduces surgery and scarring

Image credit – Winston Salem Dermatology Center CANCER DIGEST – Jan. 11, 2025 – A small study has shown that a novel topical treatment...

CANCER DIGEST – Sept. 16, 2024 – Long-term data from an international trial of immunotherapy for advanced melanoma show longer overall...

CANCER DIGEST – March 9, 2024 – Scientists continue to find better ways to detect skin cancer. (See DermaSensor device.) In the journal...

CANCER DIGEST – Feb. 16, 2024 – The FDA today has approved a new T-cell therapy for the treatment of melanoma. The therapy called...